MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors

Clinical trial NCT00207103 · COMPLETED

Trial details

NCT number: NCT00207103
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Tumors Neoplasm Metastasis

Start date: 2004-09-01
Primary completion: 2007-10-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.